Pharma’s Golden Goose: Heart Disease Now a Profit Killer
Heart disease treatments, once a goldmine for Big Pharma, are now proving to be a major financial drain.
Markets
Read Full News
Fed Clarity Fuels Wall Street Rally, Signaling Higher Rates Ahead
Stocks and bonds rallied as a recent CPI report clarified the Fed’s outlook, reducing market uncertainty despite the potential for higher interest rates.
Diesel Surge Fuels Inflation Fears Beyond the Gas Pump
Diesel prices topping $6 signal wider inflation risks beyond fuel costs.
Polymarket Cluster Linked to Big Wins Amidst KPMG Audit Insider Trading Probe
Polymarket users saw major wins on companies audited by KPMG just as a KPMG employee faces insider trading allegations.
Weil Gotshal Hit by Mass Partner Exodus to Rival Cravath
Weil Gotshal loses top dealmaker and five partners to Cravath in significant blow.
Coinbase Co-Founder’s Secret Venezuelan Oil Gambit Revealed
Coinbase co-founder Fred Ehrsam was secretly living in a Caracas hotel, pursuing major investments in Venezuela’s oil industry.
Brooks Automation Eyes Public Markets with Confidential IPO Filing
Brooks Automation, owned by THL, has confidentially filed for an IPO.
Nuclear Power’s Unexpected Revival: Data Centers Fueling Uranium Demand
Data centers are driving a resurgence in uranium prices as they look to nuclear power to meet their massive energy needs.
Witkoff’s Crypto Windfall: Over $100M from Trump-Linked Entity
Steve Witkoff netted over $100 million from a Trump-affiliated crypto entity, with earnings spiking in 2025.
NorthSands Fuels Kelso Industries with $510M CV Deal Amidst Major Fund Closures and Executive Departures
NorthSands backs Kelso Industries with $510M, Permira nears $11B fund close, and Blackstone’s real estate head departs.